|
| Antiplatelet Trialists Collaboration |
- The research continues to be overwhelming (old and new)
- There is positive evidence supporting the benefits of aspirin as a prophylactic treatment in coronary artery disease [12]
- Aspirin continues to be protective against occlusive vascular events in patients
- Acute myocardial infarction
- Ischemic stroke
- Unstable and stable angina
- Atrial fibrillation
- Prior myocardial infarction and strokes
- A low dose 75-100mg daily is effective in long-term use
- In the acute setting, a dose of greater than 150mg is recommended to be given [13]
- Numerous data supports that the early intervention by pre-hospital personnel greatly increases survival of patients to hospital discharge [14]
- It is crucial that all patients with a suspected myocardial infarctions receive aspirin in a timely manner
|
| | | | | | |
